{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:16:51Z","timestamp":1792513011288,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    Berberine (BBR) is an isoquinoline alkaloid that is widely distributed in the plant kingdom and is commonly found in\n                    <jats:italic>Coptis chinensis<\/jats:italic>\n                    Franch. It has low bioavailability, but it can interact with gut microbiota and affect a variety of diseases. The effects of BBR in diabetes, hyperlipidemia, atherosclerosis, liver diseases, intestinal diseases, mental disorders, autoimmune diseases, and other diseases are all thought to be related to gut microbiota. This review systematically and comprehensively summarize these interactions and their effects, and describes the changes of gut microbiota after the intervention of different doses of berberine and its potential clinical consequences, in order to provide a basis for the rational application of BBR in the future clinical treatment.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2023.1187718","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T14:00:40Z","timestamp":1691071240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Berberine influences multiple diseases by modifying gut microbiota"],"prefix":"10.3389","volume":"10","author":[{"given":"Fujie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine.","volume":"14","author":"Song","year":"2020","journal-title":"Front Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/CMAR.S242329","article-title":"The anti-cancer mechanisms of berberine: a review.","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.117865","article-title":"Berberine improves intestinal barrier function and reduces inflammation, immunosuppression, and oxidative stress by regulating the NF-\u03baB\/MAPK signaling pathway in deoxynivalenol-challenged piglets.","volume":"289","author":"Tang","year":"2021","journal-title":"Environ Pollut."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s11427-019-9832-9","article-title":"Establishment of an efficient germ-free animal system to support functional microbiome research.","volume":"62","author":"Li","year":"2019","journal-title":"Sci China Life Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link.","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22097-0","article-title":"Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients.","volume":"12","author":"Maifeld","year":"2021","journal-title":"Nat Commun."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709629","article-title":"Multi-pharmacology of berberine in atherosclerosis and metabolic diseases: potential contribution of gut microbiota.","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.854885","article-title":"The mechanism of berberine alleviating metabolic disorder based on gut microbiome.","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010031","article-title":"Effects of consuming calcium-rich foods on the incidence of type 2 diabetes mellitus.","volume":"11","author":"Jeon","year":"2018","journal-title":"Nutrients."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice.","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56743-x","article-title":"The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.","volume":"10","author":"Ducastel","year":"2020","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic effects of gegen qinlian decoction via the gut microbiota are attributable to its key ingredient berberine.","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinformatics."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110669","article-title":"Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.","volume":"131","author":"Yao","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00942-7","article-title":"Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study.","volume":"13","author":"Ming","year":"2021","journal-title":"Genome Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110953","article-title":"Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db\/db mice.","volume":"132","author":"Li","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119928","article-title":"Berberine combined with stachyose improves glycometabolism and gut microbiota through regulating colonic microRNA and gene expression in diabetic rats.","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1039\/c8fo00836a","article-title":"Ethanol extract of Ganoderma lucidum ameliorates lipid metabolic disorders and modulates the gut microbiota composition in high-fat diet fed rats.","volume":"9","author":"Guo","year":"2018","journal-title":"Food Funct."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03623-0","article-title":"Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia.","volume":"20","author":"Chen","year":"2022","journal-title":"J Transl Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jare.2021.07.011","article-title":"Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR\u2019s cholesterol-decreasing efficacy in patients.","volume":"37","author":"Wu","year":"2022","journal-title":"J Adv Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000449507","article-title":"Modulation of microbiota-gut-brain axis by berberine resulting in improved metabolic status in high-fat diet-fed rats.","volume":"9","author":"Sun","year":"2016","journal-title":"Obes Facts."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.7150\/thno.18290","article-title":"Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine.","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2003176","article-title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.","volume":"14","author":"Wang","year":"2022","journal-title":"Gut Microbes."},{"key":"B25","first-page":"197","article-title":"Modulation of gut microbiota by berberine improves steatohepatitis in high-fat diet-fed BALB\/C mice.","volume":"19","author":"Cao","year":"2016","journal-title":"Arch Iran Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4103\/pm.pm_584_16","article-title":"Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats.","volume":"13","author":"Li","year":"2017","journal-title":"Pharmacogn Mag."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.750826","article-title":"Berberine alleviates non-alcoholic steatohepatitis through modulating gut microbiota mediated intestinal FXR activation.","volume":"12","author":"Shu","year":"2021","journal-title":"Front Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.112","article-title":"Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease.","volume":"10","author":"Li","year":"2020","journal-title":"Clin Transl Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque.","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial.","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA."},{"key":"B31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis.","volume":"592","author":"Libby","year":"2021","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/HCO.0000000000000445","article-title":"Gut microbiome and its role in cardiovascular diseases.","volume":"32","author":"Ahmadmehrabi","year":"2017","journal-title":"Curr Opin Cardiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00205-8","article-title":"Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.","volume":"7","author":"Li","year":"2021","journal-title":"NPJ Biofilms Microbiomes."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.biopha.2018.08.148","article-title":"Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-\/- mice.","volume":"107","author":"Shi","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2017.11.023","article-title":"Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe(-\/-) mice.","volume":"268","author":"Zhu","year":"2018","journal-title":"Atherosclerosis."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02247","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease.","volume":"9","author":"Zuo","year":"2018","journal-title":"Front Microbiol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/apt.13236","article-title":"Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.","volume":"42","author":"Cas\u00e9n","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MIB.0000000000000602","article-title":"Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood-adulthood transition.","volume":"22","author":"Putignani","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease.","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat Microbiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105358","article-title":"Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.","volume":"164","author":"Jing","year":"2021","journal-title":"Pharmacol Res."},{"key":"B42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway.","volume":"18","author":"Dong","year":"2022","journal-title":"Int J Biol Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00253-019-10307-1","article-title":"Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats.","volume":"104","author":"Liao","year":"2020","journal-title":"Appl Microbiol Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108329","article-title":"Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.","volume":"101","author":"Zheng","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051506","article-title":"Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms.","volume":"13","author":"Altomare","year":"2021","journal-title":"Nutrients."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1111\/apt.16625","article-title":"Review article: current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M).","volume":"54","author":"Nee","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41401-020-00601-4","article-title":"Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01210","article-title":"Synergistic effect of berberine-based chinese medicine assembled nanostructures on diarrhea-predominant irritable bowel syndrome in vivo.","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","article-title":"Gut microbiota imbalance and colorectal cancer.","volume":"22","author":"Gagni\u00e8re","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"32013","DOI":"10.18632\/oncotarget.5166","article-title":"Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588079","article-title":"A holistic view of berberine inhibiting intestinal carcinogenesis in conventional mice based on microbiome-metabolomics analysis.","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092298","article-title":"The effects of berberine on the gut microbiota in Apc (min\/+) mice fed with a high fat diet.","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040726","article-title":"Pre-Administration of berberine exerts chemopreventive effects in AOM\/DSS-Induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota.","volume":"14","author":"Deng","year":"2022","journal-title":"Nutrients."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.814871","article-title":"Therapeutic effects of berberine on liver fibrosis are associated with lipid metabolism and intestinal flora.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-175","article-title":"Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach.","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines.","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8930374","article-title":"Hypoglycemic mechanism of the berberine organic acid salt under the synergistic effect of intestinal flora and oxidative stress.","volume":"2018","author":"Cui","year":"2018","journal-title":"Oxid Med Cell Longev."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01967","article-title":"Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels.","volume":"9","author":"Ye","year":"2018","journal-title":"Front Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s11427-017-9202-0","article-title":"Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis.","volume":"61","author":"Qin","year":"2018","journal-title":"Sci China Life Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.brainresbull.2017.08.008","article-title":"Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice.","volume":"134","author":"Liu","year":"2017","journal-title":"Brain Res Bull."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105439","article-title":"Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.","volume":"165","author":"Fang","year":"2021","journal-title":"Pharmacol Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1142\/S0192415X21500920","article-title":"Effects of berberine on gut microbiota in patients with mild metabolic disorders induced by olanzapine.","volume":"49","author":"Pu","year":"2021","journal-title":"Am J Chin Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00213-018-5102-6","article-title":"Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome.","volume":"236","author":"Skonieczna-\u017bydecka","year":"2019","journal-title":"Psychopharmacology."},{"key":"B65","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41396-021-01016-7","article-title":"Compositional and genetic alterations in Graves\u2019 disease gut microbiome reveal specific diagnostic biomarkers.","volume":"15","author":"Zhu","year":"2021","journal-title":"ISME J."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.826067","article-title":"The potential prebiotic berberine combined with methimazole improved the therapeutic effect of graves\u2019 disease patients through regulating the intestinal microbiome.","volume":"12","author":"Han","year":"2021","journal-title":"Front Immunol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106270","article-title":"Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis.","volume":"81","author":"Du","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/jcmm.17158","article-title":"Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition.","volume":"26","author":"Zhao","year":"2022","journal-title":"J Cell Mol Med."},{"key":"B69","article-title":"Berberine promotes induction of immunological tolerance to an allograft via downregulating memory CD8(+) T-Cells through altering the gut microbiota.","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"12311","DOI":"10.1096\/fj.201900425RR","article-title":"The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply.","volume":"33","author":"Yue","year":"2019","journal-title":"FASEB J."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00456-5","article-title":"Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota.","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0022034518797275","article-title":"Berberine ameliorates periodontal bone loss by regulating gut microbiota.","volume":"98","author":"Jia","year":"2019","journal-title":"J Dent Res."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1367-7","article-title":"Dose-response effect of berberine on bile acid profile and gut microbiota in mice.","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Complement Altern Med."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109002","article-title":"Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis.","volume":"116","author":"Yue","year":"2019","journal-title":"Biomed Pharmacother."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1187718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T14:00:53Z","timestamp":1691071253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1187718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":74,"alternative-id":["10.3389\/fnut.2023.1187718"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1187718","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"article-number":"1187718"}}